Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 4:9:849247.
doi: 10.3389/fcvm.2022.849247. eCollection 2022.

Case Report: Treatment Planning Study to Demonstrate Feasibility of Transthoracic Ultrasound Guidance to Facilitate Ventricular Tachycardia Ablation With Protons

Rosalind Perrin  1 , Patrick Maguire  2 , Adriano Garonna  1 , Georg Weidlich  3 , Shelley Bulling  4 , Marie Fargier-Voiron  4 , Cedric De Marco  4 , Eleonora Rossi  5 , Mario Ciocca  5 , Viviana Vitolo  5 , Alfredo Mirandola  5
Affiliations
Case Reports

Case Report: Treatment Planning Study to Demonstrate Feasibility of Transthoracic Ultrasound Guidance to Facilitate Ventricular Tachycardia Ablation With Protons

Rosalind Perrin et al. Front Cardiovasc Med. .

Abstract

Background: Cardiac arrhythmias, such as ventricular tachycardia, are disruptions in the normal cardiac function that originate from problems in the electrical conduction of signals inside the heart. Recently, a non-invasive treatment option based on external photon or proton beam irradiation has been used to ablate the arrhythmogenic structures. Especially in proton therapy, based on its steep dose gradient, it is crucial to monitor the motion of the heart in order to ensure that the radiation dose is delivered to the correct location. Transthoracic ultrasound imaging has the potential to provide guidance during this treatment delivery. However, it has to be noted that the presence of an ultrasound probe on the chest of the patient introduces constraints on usable beam angles for both protons and photon treatments. This case report investigates the possibility to generate a clinically acceptable proton treatment plan while the ultrasound probe is present on the chest of the patient.

Case: A treatment plan study was performed based on a 4D cardiac-gated computed tomography scan of a 55 year-old male patient suffering from refractory ventricular tachycardia who underwent cardiac radioablation. A proton therapy treatment plan was generated for the actual treatment target in presence of an ultrasound probe on the chest of this patient. The clinical acceptability of the generated plan was confirmed by evaluating standard target dose-volume metrics, dose to organs-at-risk and target dose conformity and homogeneity.

Conclusion: The generation of a clinically acceptable proton therapy treatment plan for cardiac radioablation of ventricular tachycardia could be performed in the presence of an ultrasound probe on the chest of the patient. These results establish a basis and justification for continued research and product development for ultrasound-guided cardiac radioablation.

Keywords: cardiac motion monitoring; protons; stereotactic radioablation; ultrasound; ventricular tachycardia.

PubMed Disclaimer

Conflict of interest statement

PM is founder and owner of MedDevicePharma LLC. GW is founder and owner of National Medical Physics and Dosimetry Company. PM and GW are consultants to EBAMed SA. RP was previously employed and AG is still employed by EBAMed SA. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Prototype version of the EBAMed proprietary US probe system (a) equipped with an optical localization marker (b) and a probe holder with strap (c) that allows for fixation to the patient's chest.
Figure 2
Figure 2
Sagittal slice of the single beam proton plan generated for the VT patient. The location of the virtual US probe with localization marker on the chest of the patient is shown in orange.
See this image and copyright information in PMC

References

    1. Chiu MH, Mitchell LB, Ploquin N, Faruqi S, Kuriachan VP. Review of stereotactic arrhythmia radioablation therapy for cardiac tachydysrhythmias. CJC Open. (2021) 11:6. 10.1016/j.cjco.2020.11.006 - DOI - PMC - PubMed
    1. Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia - supplementary appendix. N Engl J Med=. (2017) 377:2325–36. 10.1056/NEJMoa1613773 - DOI - PMC - PubMed
    1. Lydiard S, Blanck O, Hugo G, O'Brien R, Keall P. A review of cardiac radioablation (CR) for arrhythmias: procedures, technology and future opportunities. Int J Radiat Oncol Biol Phys. (2021) 109:783–800. 10.1016/j.ijrobp.2020.10.036 - DOI - PubMed
    1. Miszczyk M, Jadczyk T, Gołba K, Wojakowski W, Wita K, Bednarek J, et al. Clinical evidence behind stereotactic radiotherapy for the treatment of ventricular tachycardia (STAR)—a comprehensive review. J Clin Med. (2021) 10:1238. 10.3390/jcm10061238 - DOI - PMC - PubMed
    1. Siedow M, Brownstein J, Prasad R, Loccoh E, Harfi TT, Okabe T, et al. Cardiac radioablation in the treatment of ventricular tachycardia. Clin Transl Radiat Oncol. (2021) 31:71–9. 10.1016/j.ctro.2021.02.005 - DOI - PMC - PubMed

Publication types

LinkOut - more resources